Literature DB >> 14566101

Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by alphaMSH and ORG 2766.

Frank P T Hamers1, Jeroen Wijbenga, Francisca L C Wolters, Sjaak F L Klis, Steven Sluyter, Guido F Smoorenburg.   

Abstract

It has been shown that alphaMSH and the nonmelanotropic ACTH/MSH(4-9) analog ORG 2766 can ameliorate cisplatin-induced neurotoxicity and ototoxicity. Here, we investigated whether these peptides delay the occurrence of the cisplatin-induced shift in auditory threshold, and whether they affect the subsequent recovery of cochlear potentials. Chronically implanted round window electrodes were used to obtain daily recordings of auditory nerve compound action potentials (CAP) and cochlear microphonics at frequencies ranging from 2 to 16 kHz. Cisplatin (1.5 mg/kg i.p.) plus alphaMSH, ORG 2766 (75 mug/kg s.c.), or saline were injected daily until the 40-dB CAP threshold shift at 8 kHz was reached. Endocochlear potential (EP) was measured either 1-2 days or 28 days later, followed by morphometric analysis of the cochlea. Peptide cotreatment did not consistently delay the threshold shift; however, the CAP threshold recovered faster and to a greater extent, with the potency order being alphaMSH > ORG 2766 > saline. Significant recovery at the 2 highest frequencies was seen in the alphaMSH-treated animals only. CAP amplitude at high sound pressures, which depends more on nerve function than on outer hair cell (OHC) function, decreased severely in all groups but recovered significantly in the alphaMSH- and completely in the ORG-2766-cotreated group. EP was significantly lower in the first days after the threshold shift but had completely recovered at 28 days. Morphometric analysis of the spiral ganglion also indicated involvement of ganglion cells. OHC loss was most severe in the basal turn of saline-cotreated animals. These data suggest that the cisplatin-induced acute threshold shift might be due to reversible strial failure, whereas subsequent OHC survival determines the final degree of functional recovery. Both OHC loss and neuronal function were ameliorated by peptide cotreatment. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566101     DOI: 10.1159/000073515

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  8 in total

1.  Bilateral sensorineural hearing loss after adjuvant treatment with cyclophosphamide, methotrexate, Fluorouracil and alternative oral medications in a male with breast cancer.

Authors:  Gino Marioni; Matteo Lodo; Giuseppe Cartei; Anna Maria Zangaglia; Alberto Staffieri
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

2.  Genetic dependence of cochlear cells and structures injured by noise.

Authors:  Kevin K Ohlemiller; Patricia M Gagnon
Journal:  Hear Res       Date:  2006-12-18       Impact factor: 3.208

Review 3.  Chemical exposure and hearing loss.

Authors:  Pierre Campo; Thais C Morata; OiSaeng Hong
Journal:  Dis Mon       Date:  2013-04       Impact factor: 3.800

Review 4.  Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.

Authors:  Corné J Kros; Peter S Steyger
Journal:  Cold Spring Harb Perspect Med       Date:  2019-11-01       Impact factor: 6.915

5.  Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane.

Authors:  H Jie; S Tao; L Liu; L Xia; A Charko; Z Yu; M Bance; S Yin; G S Robertson; J Wang
Journal:  Gene Ther       Date:  2015-03-26       Impact factor: 5.250

6.  Intratympanic Diltiazem-Chitosan Hydrogel as an Otoprotectant Against Cisplatin-Induced Ototoxicity in a Mouse Model.

Authors:  James G Naples; Michael J Ruckenstein; Jarnail Singh; Brandon C Cox; Daqing Li
Journal:  Otol Neurotol       Date:  2020-01       Impact factor: 2.619

7.  Umbilical Cord Mesenchymal Stromal Cell-Derived Exosomes Rescue the Loss of Outer Hair Cells and Repair Cochlear Damage in Cisplatin-Injected Mice.

Authors:  Stella Chin-Shaw Tsai; Kuender D Yang; Kuang-Hsi Chang; Frank Cheau-Feng Lin; Ruey-Hwang Chou; Min-Chih Li; Ching-Chang Cheng; Chien-Yu Kao; Chie-Pein Chen; Hung-Ching Lin; Yi-Chao Hsu
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

Review 8.  Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies.

Authors:  Angela Callejo; Lara Sedó-Cabezón; Ivan Domènech Juan; Jordi Llorens
Journal:  Toxics       Date:  2015-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.